Capricorn Fund Managers »

Cytokinetics shares owned by Capricorn Fund Managers

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by Capricorn Fund Managers from 13F filings

Historical chart of Capricorn Fund Managers investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by Capricorn Fund Managers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by Capricorn Fund Managers

Quarter filed Position value Share count Share price at filing
2026-06-30 $7.0M 82k 85.19

More positions owned by Capricorn Fund Managers

Lpl Financial Holdings (LPLA)
Kkr & Co (KKR)
BP Sponsored Adr (BP)
Shell Spon Ads (SHEL)
Applovin Corp Com Cl A (APP)
Carvana Cl A (CVNA)
Boost Run Inc-cl A Ord Shs Cl A
ING Groep NV Sponsored Adr (ING)
British American Tobacco Sponsored Adr (BTI)
Bank of America Corporation (BAC)
Brookdale Senior Living (BKD)
Affiliated Managers (AMG)
GSK Sponsored Adr (GSK)
NRG Energy Com New (NRG)
Axogen (AXGN)

View all positions for Capricorn Fund Managers

Top funds holding Cytokinetics

BlackRock
FMR
Wellington Management Company
Vanguard Portfolio Management
State Street Corporation
Vanguard Capital Management
venBio Select Advisor
Geode Capital Management
Bank of America Corporation
Rtw Investments
Armistice Capital
Integral Health Asset Management
Goldman Sachs Group
Susquehanna International
UBS Group

View all funds holding Cytokinetics